Hsbc Holdings PLC Buys Shares of 12,346 Chemed Corporation $CHE

Hsbc Holdings PLC purchased a new stake in shares of Chemed Corporation (NYSE:CHE) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 12,346 shares of the company’s stock, valued at approximately $5,729,000.

Several other institutional investors have also modified their holdings of CHE. Monetary Solutions Ltd bought a new stake in Chemed in the 4th quarter valued at about $25,000. Los Angeles Capital Management LLC acquired a new position in Chemed during the 4th quarter valued at about $26,000. BOK Financial Private Wealth Inc. bought a new position in Chemed in the 4th quarter worth about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Chemed in the 2nd quarter worth about $34,000. Finally, Versant Capital Management Inc grew its position in Chemed by 7,500.0% in the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after purchasing an additional 75 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

CHE has been the topic of a number of recent analyst reports. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Oppenheimer raised their target price on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research report on Friday, July 31st. Royal Bank Of Canada increased their price target on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Finally, Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $530.75.

Insider Activity at Chemed

In other Chemed news, Director Patrick P. Grace sold 190 shares of the company’s stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the transaction, the director owned 3,533 shares in the company, valued at approximately $1,879,556. This represents a 5.10% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 6,537 shares of company stock worth $3,406,014 in the last 90 days. 3.33% of the stock is owned by corporate insiders.

Chemed Stock Up 0.6%

Shares of Chemed stock opened at $523.57 on Friday. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $557.00. The company has a market cap of $6.84 billion, a P/E ratio of 26.30, a P/E/G ratio of 1.97 and a beta of 0.51. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. The stock has a 50-day moving average price of $509.45 and a 200 day moving average price of $449.67.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, analysts expect that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a dividend of $0.70 per share. The ex-dividend date of this dividend is Monday, August 17th. This is a boost from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. Chemed’s payout ratio is presently 14.06%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.